TRPC1 and fragile X syndrome: In the present study, to avoid any potential developmental impairment consecutive to the early age deletion of Trpc1 gene, FXS C1 and FXS C1-cKO underwent MWM assay, followed subsequently by tamoxifen injection to acutely inhibit TRPC1 expression in neurons of the forebrain.